Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Antigens”

316 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 316 results

Not applicableStudy completedNCT01672411
What this trial is testing

Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer

Who this might be right for
Prostate Cancer
University Of Perugia 250
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Testing effectiveness (Phase 2)Study completedNCT01431391
What this trial is testing

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmProstate CancerProstatic Adenocarcinoma
Dendreon 68
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableStudy completedNCT00630188
What this trial is testing

Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial

Who this might be right for
Prostatic Neoplasms
University of North Carolina 128
Testing effectiveness (Phase 2)Ended earlyNCT01194960
What this trial is testing

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Hormone Refractory Prostate Cancer
Oxford BioMedica 25
Not applicableUnknownNCT04393376
What this trial is testing

PSA Glycomics Assay for Early Detection of Prostate Cancer

Who this might be right for
Prostate CancerPSA
Prof.dr. H.P. Beerlage 150
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Large-scale testing (Phase 3)Study completedNCT02680041
What this trial is testing

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 221
Testing effectiveness (Phase 2)Looking for participantsNCT05761366
What this trial is testing

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Who this might be right for
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 400
Not applicableStudy completedNCT02319239
What this trial is testing

Prostate Cancer Stereotactic Radiotherapy

Who this might be right for
Prostate NeoplasmsToxicity Due to Radiotherapy
Tampere University Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01994239
What this trial is testing

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

Who this might be right for
Adenocarcinoma of Prostate
UNICANCER 120
Testing effectiveness (Phase 2)Study completedNCT03604757
What this trial is testing

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

Who this might be right for
Prostate Cancer
University Hospital, Bordeaux 22
Testing effectiveness (Phase 2)Study completedNCT00109811
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849298
What this trial is testing

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Who this might be right for
Prostatic Neoplasm
Novartis Pharmaceuticals 49
Post-approval studies (Phase 4)Ended earlyNCT00629330
What this trial is testing

Dissemination of Prostate Cancer Screening to PCP's in African American Communities

Who this might be right for
Prostate Cancer
Columbia University 86
Not applicableStudy completedNCT00490763
What this trial is testing

Active Surveillance in Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 1,139
Not applicableUnknownNCT04773821
What this trial is testing

Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 260
Not applicableStudy completedNCT01178840
What this trial is testing

Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom

Who this might be right for
Birth Control
CONRAD 505
Not applicableStudy completedNCT03187990
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Who this might be right for
Prostate Cancer
Irene Burger 52
Load More Results